Villalobos Bollen, M. A., Czapiewski, P., Reinmuth, N., Fischer, J., Andreas, S., Kortsik, C., . . . Thomas, M. (2018). ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer. Medical oncology, 35, . https://doi.org/10.1007/s12032-018-1169-5
Chicago-Zitierstil (17. Ausg.)Villalobos Bollen, Matthias Americo, et al. "ERCC1 Assessment in Upfront Treatment with and Without Cisplatin-based Chemotherapy in Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer." Medical Oncology 35 (2018). https://doi.org/10.1007/s12032-018-1169-5.
MLA-Zitierstil (9. Ausg.)Villalobos Bollen, Matthias Americo, et al. "ERCC1 Assessment in Upfront Treatment with and Without Cisplatin-based Chemotherapy in Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer." Medical Oncology, vol. 35, 2018, https://doi.org/10.1007/s12032-018-1169-5.